"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we've gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments, and email. This allows you to still get great care while helping to address the community spread of COVID-19. If you're concerned about your specific health condition, call 1-833-KP4CARE (1-833-574-2273) (TTY 711) to talk to a licensed care provider 24/7. For answers to your general questions about COVID-19, call our new information line for Kaiser Permanente members at 1-877-813-7297."

During the past decade, Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 13 clinical trials were completed, i.e. on average, 118.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" #1 sponsor was "Children's Oncology Group" with 22 trials, followed by "NSABP Foundation Inc" with 9 trials sponsored, "Milton S. Hershey Medical Center" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "CancerVax Corporation" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" are "Breast Cancer" (9 trials), "Leukemia" (9 trials), "Lymphoma" (5 trials), "Sarcoma" (5 trials) and "Asthma" (4 trials). Many other conditions were trialed in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" are "Drug" (48 trials), "Biological" (19 trials), "Procedure" (11 trials), "Radiation" (8 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (15 trials), "filgrastim" (10 trials), "vincristine sulfate" (9 trials), "Placebo" (8 trials) and "radiation therapy" (8 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego" are 53 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".